The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization

Inhibition of hypoxia-inducible factor 1 with acriflavine sensitizes hypoxic tumor cells to photodynamic therapy with zinc phthalocyanine-encapsulating cationic liposomes

(2016) Mans Broekgaarden et al.   Nano Research

A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration

(2016) Glenn J. Jaffe et al.   OPHTHALMOLOGY

Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression

(2016) Peter A. Campochiaro et al.   OPHTHALMOLOGY

Treatment of Diabetic Macular Edema with an Inhibitor of Vascular Endothelial-Protein Tyrosine Phosphatase That Activates Tie2

(2015) Peter A. Campochiaro et al.   OPHTHALMOLOGY

Molecular pathogenesis of retinal and choroidal vascular diseases

(2015) Peter A. Campochiaro   PROGRESS IN RETINAL AND EYE RESEARCH

Sustained delivery of a HIF-1 antagonist for ocular neovascularization

(2013) Takeshi Iwase et al.   JOURNAL OF CONTROLLED RELEASE

A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells

(2013) Elena Miranda et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Long-term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression

(2012) Michael S. Ip   ARCHIVES OF OPHTHALMOLOGY

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

(2012) Jeffrey S. Heier et al.   OPHTHALMOLOGY

Ranibizumab for Diabetic Macular Edema

(2012) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Digoxin inhibits retinal ischemia-induced HIF-1α expression and ocular neovascularization

(2010) Tsunehiko Yoshida et al.   FASEB JOURNAL

Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion

(2010) Peter A. Campochiaro et al.   OPHTHALMOLOGY

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

(2010) David M. Brown et al.   OPHTHALMOLOGY

Suprachoroidal Drug Delivery to the Back of the Eye Using Hollow Microneedles

(2010) Samirkumar R. Patel et al.   PHARMACEUTICAL RESEARCH

Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells

(2009) K. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization

(2009) K. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema

(2008) John Doukas et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator

(2008) Peter A Campochiaro et al.   MOLECULAR THERAPY

Digoxin and other cardiac glycosides inhibit HIF-1  synthesis and block tumor growth

(2008) H. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA